High-throughput screening

High-Throughput Screening (HTS) Market worth $44.5 billion | MarketsandMarkets

Retrieved on: 
Wednesday, July 5, 2023
Aurora, Bio-Rad Laboratories, Charles River Laboratories, BMG, Corning Inc., Drug development, Therapy, Crown Bioscience International, Czech Republic, Innovative Interstellar Explorer, Product-service system, Agriculture, Disease resistance, High-throughput screening, Rest of the world in sports and games, Merck Group, Research, HTS, Gesellschaft mit beschränkter Haftung, Danaher Corporation, Creative Biolabs, Promega, PerkinElmer, Translational research, Agilent Technologies, Drug discovery, Robotics, Health, Automation, Fine chemical, Pharmaceutical industry, Compact Disc manufacturing, Retail

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=134981950

Key Points: 
  • Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=134981950
    High-Throughput Screening (HTS) Market Advantages:
    Accelerated Drug Discovery: High-throughput screening (HTS) expedites the drug discovery process by quickly screening a large number of compounds against specific targets.
  • Target-specific Screening: HTS enables researchers to target specific molecular pathways or cellular functions, allowing for more focused screening.
  • High-Throughput Screening Market- Report Highlights:
    Refinements in the segments of the global high-throughput screening market:
    Company profiles give a glimpse of the key players in the market with respect to business overviews, financials, product offerings, and recent developments.
  • The biochemical screening and life sciences research segments were newly added to the application chapter of the current edition of the high-throughput screening market report.

High-Throughput Screening (HTS) Market worth $44.5 billion | MarketsandMarkets

Retrieved on: 
Wednesday, July 5, 2023
Aurora, Bio-Rad Laboratories, Charles River Laboratories, BMG, Corning Inc., Drug development, Therapy, Crown Bioscience International, Czech Republic, Innovative Interstellar Explorer, Product-service system, Agriculture, Disease resistance, High-throughput screening, Rest of the world in sports and games, Merck Group, Research, HTS, Gesellschaft mit beschränkter Haftung, Danaher Corporation, Creative Biolabs, Promega, PerkinElmer, Translational research, Agilent Technologies, Drug discovery, Robotics, Health, Automation, Fine chemical, Pharmaceutical industry, Compact Disc manufacturing, Retail

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=134981950

Key Points: 
  • Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=134981950
    High-Throughput Screening (HTS) Market Advantages:
    Accelerated Drug Discovery: High-throughput screening (HTS) expedites the drug discovery process by quickly screening a large number of compounds against specific targets.
  • Target-specific Screening: HTS enables researchers to target specific molecular pathways or cellular functions, allowing for more focused screening.
  • High-Throughput Screening Market- Report Highlights:
    Refinements in the segments of the global high-throughput screening market:
    Company profiles give a glimpse of the key players in the market with respect to business overviews, financials, product offerings, and recent developments.
  • The biochemical screening and life sciences research segments were newly added to the application chapter of the current edition of the high-throughput screening market report.

Gubbs Joins the Tetra Partner Network to Increase and Enhance Data Processing Throughput

Retrieved on: 
Thursday, December 8, 2022
Cloud, Tetra, Laboratory, Therapy, Partnership, Metadata, Science, High-throughput screening, FDA, Drug development, Title 21 CFR Part 11, ADME, Medical device, Gubb (application)

BOSTON, Dec. 8, 2022 /PRNewswire/ -- TetraScience , the Scientific Data Cloud company, announced today that Gubbs , a leader in lab optimization and validation software, has joined the Tetra Partner Network to increase and enhance data processing throughput with the Tetra Scientific Data Cloud .

Key Points: 
  • BOSTON, Dec. 8, 2022 /PRNewswire/ -- TetraScience , the Scientific Data Cloud company, announced today that Gubbs , a leader in lab optimization and validation software, has joined the Tetra Partner Network to increase and enhance data processing throughput with the Tetra Scientific Data Cloud .
  • "Gubbs is dedicated to providing class-leading software to the biotech and pharma industries," said Simon Meffan-Main Ph.D., VP, Tetra Partner Network.
  • Gubbs customers can take advantage of Tetra Data, expanding the types of source data and increasing accessibility to data for better and faster analysis.
  • "We are excited to join the Tetra Partner Network so customers can benefit from the increased data processing throughput with GMSU and the Tetra Data Platform," said Larry Elvebak, Founder and CEO, Gubbs.

Lab Automation Global Market Report 2022: Amalgamation of AI and Analytical Tools in Laboratory Workflows Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 1, 2022
Software, Technology, Biotechnology, Health, Vision Guided Robotic Systems, Hospital, Use, Strategic management, Research, Value, Ortho Clinical Diagnostics, Laboratory information management system, LIMS, Collaborative Drug Discovery, Biotechnology, Customer support, Electronic lab notebook, Market share analysis, Business Growth Fund, Reader-response criticism, Research report, Standardization in Lab Automation, HTS, Robotic arm, COVID-19, Growth, Cumulative distribution function, LES, High-throughput screening, Workcell, Luminescence, Automated pipetting system, Royal Belfast Academical Institution, ASRS, EIA, Acquisition, SDMS, ELN, Compound management, Drug discovery, Automation, Automated storage and retrieval system, Economic development, Climate Monitoring and Diagnostics Laboratory, Equipment, Fine chemical, Retail, Software, Application

The Global Lab Automation Market is projected to grow with a significant CAGR in the forecast period.

Key Points: 
  • The Global Lab Automation Market is projected to grow with a significant CAGR in the forecast period.
  • Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities.
  • Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the Global Lab Automation Market.
  • The Off-The-Shelf Automated Workcells is further studied across Post-Analytical Automated Systems, Pre-Analytical Automated Systems, and Total Lab Automation Systems.

Insights on the High-Throughput Screening Global Market to 2027 - Government Funding and Venture Capital Investments Present Opportunities - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 5, 2022
Internet, Medical Devices, Health, Technology, Software, Use, Growth, Strategic management, CAGR, Global, High-throughput screening, Customer support, Investment, Certification, R, Decision-making, Acquisition, Market share analysis, Value, COVID-19, USD, Business Growth Fund, Retail, Fine chemical, Powder metallurgy

Which are the products/segments/applications/areas to invest in over the forecast period in the Global High-Throughput Screening Market?

Key Points: 
  • Which are the products/segments/applications/areas to invest in over the forecast period in the Global High-Throughput Screening Market?
  • What is the competitive strategic window for opportunities in the Global High-Throughput Screening Market?
  • What is the market share of the leading vendors in the Global High-Throughput Screening Market?
  • What modes and strategic moves are considered suitable for entering the Global High-Throughput Screening Market?

Q-State Biosciences Announces New Peer Reviewed Publication Introducing Its Next Generation Swarm™ Optogenetic Measurement Technology System

Retrieved on: 
Wednesday, July 13, 2022
Science, Neurology, Cardiology, Other Science, Biotechnology, Research, Pharmaceutical, Health, Nav1.7, Drug discovery, Ion, Frontiers, Patient, Paper, Brain, Therapy, Collection, High-throughput screening, Pain, Research, Neurological disorder, CNS, Drug development, Medical device

Q-State Biosciences (Q-State), a discovery technology and therapeutics company advancing programs for the treatment of serious central nervous system disorders, announced today the publication of a peer reviewed original research article in Frontiers in Molecular Neuroscience.

Key Points: 
  • Q-State Biosciences (Q-State), a discovery technology and therapeutics company advancing programs for the treatment of serious central nervous system disorders, announced today the publication of a peer reviewed original research article in Frontiers in Molecular Neuroscience.
  • The paper, titled Highly Parallelized, Multicolor Optogenetic Recordings of Cellular Activity for Therapeutic Discovery Applications in Ion Channels and Disease-associated Excitable Cells , highlights Q-States proprietary Swarm technology system.
  • The publication is part of a special research topic collection entitled Targeting Ion Channels for Drug Discovery: Emerging Challenges for High Throughput Screening Technologies.
  • The paper details the design and operating capabilities of the new Swarm system, including its use applications in neuronal and cardiac model systems to broadly quantify cellular activity.

Organs-On-Chips Market size worth $ 300.89 Million, Globally, by 2028 at 36.90% CAGR: Verified Market Research®

Retrieved on: 
Tuesday, July 5, 2022
Interactivity, EMT, Research, NGS, Molecular diagnostics, Metal, Defense, Transport, Gene expression, Consumables, SME, VMI, DNA microarray, Data collection, Energy, Geography, Biochip, Information and communications technology, New product development, Building & Construction Trades Council v. Associated Builders & Contractors of Massachusetts/Rhode Island, Inc., Time, Biotechnology, Mineral, Medical device, Ministry of Energy (Power Division), High-throughput screening, Key, National Virus Reference Laboratory, Polymerase, Information, Validation, PCR, Market research, DNA sequencing, Polymerase chain reaction, Automatic meter reading, DNA profiling, R, Drug discovery, Automotive industry, DNA, Reagent, Fine chemical, Hospital, Software, Medication, Mining, Technology, Health care, Microsoft Excel, Chemical substance

JERSEY CITY, N.J., July 5, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Organs-On-Chips Market" By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes), By Application (Physiological Model Development, Drug Discovery, and Toxicology Research), By Offering (Products and Services), By Type (Liver, Heart, Lung, Kidney), and By Geography. According to Verified Market Research, the Organs-On-Chips Market size was valued at USD 21.36 Million in 2020 and is projected to reach USD 300.89 Million by 2028, growing at a CAGR of 36.90% from 2021 to 2028.

Key Points: 
  • VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market.
  • VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.
  • Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers.
  • Verified Market Research provides advanced analytical research solutions while offering information enriched research studies.

Worldwide Liquid Handling System Industry to 2027 - Increasing Research Activities in Genomics and Proteomics Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 9, 2021
Other Manufacturing, Manufacturing, Biotechnology, Geography, PCR, Research, Laboratory, COVID-19, Automation, NGS, Porter's five forces analysis, Growth, Drug discovery, Infection, Ansoff Matrix, Prevalence, HTS, Drug development, High-throughput screening, Industry, User (computing), Liquid, Vaccine, Software, USD, Viral Research and Diagnostic Laboratories, Consumables, CAGR, Hospital, ELISA, Genomics, Adoption, Academic institution, Observation, Proteomics, ADME, Polymerase chain reaction, Pipette, Fine chemical, Risk management

All these help in driving the market growth of the Global Liquid Handling System Market.

Key Points: 
  • All these help in driving the market growth of the Global Liquid Handling System Market.
  • Liquid handling systems are also used to eliminate errors and minimize the processing time at laboratories.
  • Hospitals and diagnostic centers are also using automated liquid handling systems for the early detection and treatment of diseases.
  • Thus, all these factors help in boosting the market growth of the Liquid Handling System Market.

LitePoint Announces IQxel-MX Test System for Wi-Fi 7, World’s Newest and Fastest Wi-Fi Standard

Retrieved on: 
Tuesday, September 14, 2021
Cloud, Automation, SAN, AR, Engineering, PHY, Personal computer, Silicon, TM, Wi-Fi, Hertz, IEEE 802.11be, High-throughput screening, LitePoint, Computing, VR, IEEE, EVM, Augmented reality, NASDAQ, MLO, XR, Solution, Tablet, GLOBE, MIMO, Extended reality, EHT, Z-Wave, Virtual reality, Mobile phone, Internet service provider

SAN JOSE, Calif., Sept. 14, 2021 (GLOBE NEWSWIRE) -- LitePoint, a leading provider of wireless test solutions, today announced the IQxel-MXTM test system, which handles the high-performance requirements of the new Wi-Fi 7 , IEEE 802.11be standard.

Key Points: 
  • SAN JOSE, Calif., Sept. 14, 2021 (GLOBE NEWSWIRE) -- LitePoint, a leading provider of wireless test solutions, today announced the IQxel-MXTM test system, which handles the high-performance requirements of the new Wi-Fi 7 , IEEE 802.11be standard.
  • Combining these capabilities with the new multi-link modes, Wi-Fi 7 will power the future of connectivity for the most demanding wireless applications.
  • LitePoint creates wireless test solutions and services for the worlds most innovative wireless device makers, helping them to ensure their products perform for todays demanding consumers.
  • A leading innovator in wireless testing, LitePoint products come out of the box ready to test the most widely used wireless chipsets in the world.

OpenEye Scientific Partners with Enamine to Accelerate Early Drug Discovery

Retrieved on: 
Thursday, September 9, 2021

When you consider the old-fashioned way of manual screening with a million molecules in plastic trays, what we are doing with Enamine is really revolutionary."

Key Points: 
  • When you consider the old-fashioned way of manual screening with a million molecules in plastic trays, what we are doing with Enamine is really revolutionary."
  • "Giving OpenEye customers access within Orion to Enamine's turnkey, professionally prepared, and continuously updated database with billions of compounds will help our customers select candidates much earlier in the discovery process."
  • Our scientific, physics-based approach to molecular design historically focused on molecular shape and electrostatic potential to inform and guide molecular discovery and optimization.
  • OpenEye has now integrated its applications and toolkits into Orion, the only cloud-native, fully integrated molecular design platform.